Generic Drugs Office Becomes Super; Safety Organizational Challenges Remain
This article was originally published in The Pink Sheet Daily
Executive Summary
About 200 reviewers are left behind in the restructuring as CDER Director Woodcock lays the groundwork for the Office of Pharmaceutical Quality.